Abiopharma

🔍 Garber Alan M (Director)

Company: VERTEX PHARMACEUTICALS INC / MA (VRTX)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 34 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 33.90 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.